There are four globally endemic human coronaviruses which, together with the better known rhinoviruses, are responsible for causing common colds. Usually, infections with these viruses are harmless to humans, researchers said.
Christian Drosten from University Hospital of Bonn in Germany and colleagues have now found that the source of "HCoV-229E", one of the four common cold coronaviruses, also originates from camels, just like the dreaded Middle East respiratory syndrome (MERS) virus.
The MERS coronavirus was identified in humans for the first time in 2012.
"In our MERS investigations we examined about 1,000 camels for coronaviruses and were surprised to find pathogens that are related to 'HCoV-229E', the human common cold virus, in almost six per cent of the cases," said Drosten.
Further comparative molecular genetic analysis of common cold viruses in bats, humans and dromedaries suggests that this common cold virus was actually transmitted from camels to humans.
Researchers isolated live camel common cold viruses and discovered that these could principally also enter human cells - via the same receptor used by the common cold virus "HCoV-229E".
Tests with human serum and animal common cold viruses showed that there is no immediate risk of an epidemic in humans, because largest part of the human population already has immunity, owing to the widespread immunity against the common cold virus HCoV-229E.
"The MERS virus is a strange pathogen: smaller, regionally restricted outbreaks, for example in hospitals, keep occurring. Fortunately, the virus has not adapted well enough to humans, and has consequently been unable to spread globally up to now," said Drosten.
The global spread of HCoV-229E through human-to-human transmission, which is highly likely to have occurred during a past pandemic, gives rise to concern, researchers said.
"Our current study gives us a warning sign regarding the risk of a MERS pandemic - because MERS could perhaps do what HCoV-229E did," said Drosten.
The findings were published in the journal PNAS.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
